We are live on ! Find out more
Mariner

Mariner Portfolio holdings

AUM $85.7B
1-Year Est. Return 24.21%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+24.21%
3 Year Est. Return
+74.24%
5 Year Est. Return
+87.67%
10 Year Est. Return
+269.13%
AUM
$56.4B
AUM Growth
+$4.78B
Cap. Flow
+$1.89B
Cap. Flow %
3.35%
Top 10 Hldgs %
25.87%
Holding
3,434
New
281
Increased
1,727
Reduced
1,174
Closed
149

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$278M
2
NVDA icon
NVIDIA
NVDA
+$145M
3
TT icon
Trane Technologies
TT
+$95.8M
4
LULU icon
lululemon athletica
LULU
+$92.1M
5
TREE icon
LendingTree
TREE
+$83.6M

Sector Composition

Rank Sector Weight
1 Technology 19.45%
2 Financials 7.32%
3 Healthcare 5.85%
4 Consumer Discretionary 5.33%
5 Industrials 4.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INDI icon
3201
indie Semiconductor
INDI
$733M
$41.7K ﹤0.01%
+10,447
New +$50.7K
ENIC icon
3202
Enel Chile
ENIC
$5.96B
$41.6K ﹤0.01%
14,888
-2,100
-12% -$5.79K
RLMD icon
3203
Relmada Therapeutics
RLMD
$544M
$39.8K ﹤0.01%
12,274
-4,945
-29% -$16K
EDIT icon
3204
Editas Medicine
EDIT
$399M
$39.4K ﹤0.01%
+11,554
New +$50.3K
BLNK icon
3205
Blink Charging
BLNK
$75.2M
$39.2K ﹤0.01%
22,783
+2,010
+10% +$4.79K
NBP
3206
NovaBridge Biosciences American Depositary Shares
NBP
$205M
$39.1K ﹤0.01%
31,535
VEEE icon
3207
Twin Vee PowerCats
VEEE
$7.41M
$38.5K ﹤0.01%
173
+121
+233% +$22.6K
BTBT icon
3208
Bit Digital
BTBT
$484M
$37.8K ﹤0.01%
+10,752
New +$35.7K
CDLX icon
3209
Cardlytics
CDLX
$21M
$37.4K ﹤0.01%
1,170
-332
-22% -$18.4K
RPID icon
3210
Rapid Micro Biosystems
RPID
$99.1M
$37.4K ﹤0.01%
+42,000
New +$32.6K
NB
3211
NioCorp Developments
NB
$603M
$35.6K ﹤0.01%
16,338
-864
-5% -$1.58K
AILE
3212
DELISTED
iLearningEngines, Inc. Common Stock
AILE
$35.1K ﹤0.01%
+21,045
New +$107K
PRQR icon
3213
ProQR Therapeutics
PRQR
$243M
$33.5K ﹤0.01%
18,334
AVAL icon
3214
Grupo Aval
AVAL
$5.67B
$33.3K ﹤0.01%
16,394
-178,443
-92% -$374K
TALK icon
3215
Talkspace
TALK
$873M
$32K ﹤0.01%
15,314
+314
+2% +$612
CVAC
3216
DELISTED
CureVac
CVAC
$30.8K ﹤0.01%
10,312
-5,327
-34% -$17.5K
DHY
3217
Credit Suisse High Yield Credit Fund
DHY
$238M
$30.5K ﹤0.01%
+13,455
New +$28.4K
CHGG icon
3218
Chegg
CHGG
$108M
$29.3K ﹤0.01%
16,547
-872
-5% -$2.14K
BLUE
3219
DELISTED
bluebird bio
BLUE
$28.8K ﹤0.01%
2,772
KG
3220
Kestrel Group
KG
$71.3M
$28.1K ﹤0.01%
794
+25
+3% +$906
TSHA icon
3221
Taysha Gene Therapies
TSHA
$1.59B
$26.8K ﹤0.01%
+13,336
New +$29.3K
ATOM icon
3222
Atomera
ATOM
$201M
$26.3K ﹤0.01%
+10,000
New +$31.2K
BOLT icon
3223
Bolt Biotherapeutics
BOLT
$7.36M
$26.3K ﹤0.01%
+2,027
New +$27.9K
LPSN icon
3224
LivePerson
LPSN
$18.9M
$26.1K ﹤0.01%
1,360
+27
+2% +$458
ORMP icon
3225
Oramed Pharmaceuticals
ORMP
$165M
$25.7K ﹤0.01%
10,544

Similar funds

Mariner's Q3 2024 Portfolio in Review

As of Q3 2024, Mariner held 3,434 positions worth $56.4B, up 9.3% from $51.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Mariner deployed $1.89B of net new capital in Q3 2024, opening 281 new positions and adding to 1,727 existing holdings. Its largest new stake was Fidelity Fundamental Large Cap Core ETF: 1,060,968 shares worth $48.4M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apollo Global Management, an estimated $216M trimmed.

  • Mariner's largest Q3 2024 buy was Fidelity Fundamental Large Cap Core ETF: 1,060,968 shares worth $48.4M.
  • Mariner added most to Microsoft in Q3 2024, an estimated $278M increase.
  • Mariner's biggest Q3 2024 reduction was Apollo Global Management, cutting an estimated $216M.
  • Mariner fully exited UFP Technologies in Q3 2024, selling an estimated $3.43M.
  • Mariner's ten largest holdings make up 26% of its $56.4B portfolio in Q3 2024.
  • Mariner opened 281 new positions and closed 149 in Q3 2024.
  • Mariner's portfolio value rose 9.3% quarter-over-quarter to $56.4B.

Based on Mariner's 13F filing for Q3 2024, filed 13 Nov 2024.